The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hoerter Steven L. since 2013.
This trader's CIK number is 1533451.
At the time of last reporting, Hoerter Steven L. was the President and CEO of Deciphera Pharmaceuticals, Inc.. (stock ticker symbol DCPH).
Also see all insider trading activities at Deciphera Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | AGIO | 0 | $0 | 10,000 | $670,050 | 27,750 | $397,600 |
| 2018 | AGIO | 0 | $0 | 39,350 | $3,084,492 | 39,350 | $1,564,556 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | CLVS | 0 | $0 | 50,000 | $3,610,000 | 50,000 | $551,000 |
| 2013 | CLVS | 0 | $0 | 10,000 | $730,600 | 10,000 | $110,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DCPH | 0 | $0 | 59,118 | $856,766 | 0 | $0 |
| 2021 | DCPH | 0 | $0 | 0 | $0 | 1,078 | $27,381 |
| 2020 | DCPH | 0 | $0 | 0 | $0 | 3,187 | $80,947 |
1. Agios Pharmaceuticals, Inc. (AGIO)
2. Clovis Oncology, Inc. (CLVS)
3. Deciphera Pharmaceuticals, Inc. (DCPH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-01 | AGIO | Option Ex | 5,000 | 39.76 | 198,800 |
| 2019-03-04 | AGIO | Sale | 5,000 | 68.00 | 340,000 |
| 2019-03-04 | AGIO | Option Ex | 5,000 | 39.76 | 198,800 |
| 2019-03-01 | AGIO | Sale | 5,000 | 66.01 | 330,050 |
| 2019-02-16 | AGIO | Option Ex | 2,750 | .00 | 0 |
| 2019-01-20 | AGIO | Option Ex | 15,000 | .00 | 0 |
| 2018-08-24 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-08-24 | AGIO | Sale | 2,050 | 74.92 | 153,586 |
| 2018-07-25 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-07-25 | AGIO | Sale | 2,050 | 84.58 | 173,389 |
| 2018-06-22 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-06-22 | AGIO | Sale | 2,050 | 97.58 | 200,039 |
| 2018-05-23 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-05-23 | AGIO | Sale | 2,050 | 85.76 | 175,808 |
| 2018-04-23 | AGIO | Sale | 2,050 | 85.95 | 176,197 |
| 2018-04-23 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-03-22 | AGIO | Sale | 2,050 | 84.65 | 173,532 |
| 2018-03-22 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-02-22 | AGIO | Option Ex | 2,050 | 39.76 | 81,508 |
| 2018-02-22 | AGIO | Sale | 2,050 | 78.63 | 161,191 |
| 2018-01-23 | AGIO | Sale | 25,000 | 74.83 | 1,870,750 |
| 2018-01-23 | AGIO | Option Ex | 25,000 | 39.76 | 994,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-05 | CLVS | Option Ex | 20,000 | 11.02 | 220,400 |
| 2015-03-05 | CLVS | Sale | 20,000 | 80.00 | 1,600,000 |
| 2015-02-17 | CLVS | Option Ex | 10,000 | 11.02 | 110,200 |
| 2015-02-17 | CLVS | Sale | 10,000 | 72.00 | 720,000 |
| 2015-01-16 | CLVS | Sale | 10,000 | 67.00 | 670,000 |
| 2015-01-16 | CLVS | Option Ex | 10,000 | 11.02 | 110,200 |
| 2015-01-13 | CLVS | Option Ex | 10,000 | 11.02 | 110,200 |
| 2015-01-13 | CLVS | Sale | 10,000 | 62.00 | 620,000 |
| 2013-06-04 | CLVS | Option Ex | 10,000 | 11.02 | 110,200 |
| 2013-06-04 | CLVS | Sale | 10,000 | 73.06 | 730,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-30 | DCPH | Sale | 21,573 | 12.02 | 259,264 |
| 2023-03-21 | DCPH | Sale | 7,500 | 15.57 | 116,782 |
| 2023-02-14 | DCPH | Sale | 30,045 | 16.00 | 480,720 |
| 2021-01-21 | DCPH | Option Ex | 1,078 | 25.40 | 27,381 |
| 2020-08-20 | DCPH | Option Ex | 187 | 25.40 | 4,749 |
| 2020-07-20 | DCPH | Option Ex | 188 | 25.40 | 4,775 |
| 2020-06-18 | DCPH | Option Ex | 187 | 25.40 | 4,749 |
| 2020-05-28 | DCPH | Option Ex | 188 | 25.40 | 4,775 |
| 2020-04-21 | DCPH | Option Ex | 187 | 25.40 | 4,749 |
| 2020-03-18 | DCPH | Option Ex | 2,250 | 25.40 | 57,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoerter Steven L. (President and CEO of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.